TRATAMIENTO DE REEMPLAZO HORMONAL ENFOCADO EN LAS OPCIONES DE FERTILIDAD EN MUJERES CON SÍNDROME DE TURNER

Abstract

Introduction: Hormone replacement therapy in women with Turner Syndrome, focusing on estrogen, progesterone, and gonadotropins such as FSH and LH, is critical for addressing infertility associated with this genetic condition. This study reviews existing literature to assess the efficacy of these drugs in improving ovarian function and fertility options. Objective: To analyze and synthesize current literature on hormone replacement treatment options and their effectiveness in enhancing fertility in women with TS. Methodology: A literature review was conducted on medical platforms such as PubMed and MEDLINE, using keywords such as "Turner Syndrome", "Hormone Replacement Therapy", and "Fertility". Studies from the last 5 years, in both English and Spanish, focused on hormonal treatments and fertility, were included. Results: Reviewed studies indicate that drugs like estrogen and progesterone in hormone replacement therapy can improve ovarian function in women with TS. Some cases reported success using FSH and LH to stimulate ovulation. However, variability in responses and potential side effects require careful consideration. Conclusions: Treatment with estrogen, progesterone, FSH, and LH offers possibilities for fertility improvement in TS, but must be personalized and rigorously monitored to optimize outcomes and minimize risks.